Stock Events

Stock Events

SAB Biotherapeutics (SABS) Q3 2023 Earnings

13NovConfirmed

Nov 22

Q1 2023

Q2 2023

Q3 2023

-0.16

-0.14

-0.12

-0.1

Details

Expected EPS

-0.12

Actual EPS

-0.1

Surprise EPS

0.02

Surprise Percent

+16.67%

Description

SAB Biotherapeutics (SABS) has reported earnings of -0.1 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.